Growth Metrics

Quest Diagnostics (DGX) Deferred Taxes (2016 - 2026)

Quest Diagnostics' Deferred Taxes history spans 18 years, with the latest figure at $48.0 million for Q1 2026.

  • On a quarterly basis, Deferred Taxes rose 585.71% to $48.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $146.0 million, a 284.21% increase, with the full-year FY2025 number at $105.0 million, up 707.69% from a year prior.
  • Deferred Taxes hit $48.0 million in Q1 2026 for Quest Diagnostics, up from -$13.0 million in the prior quarter.
  • Over the last five years, Deferred Taxes for DGX hit a ceiling of $110.0 million in Q3 2025 and a floor of -$44.0 million in Q4 2022.
  • Historically, Deferred Taxes has averaged $6.9 million across 5 years, with a median of -$4.0 million in 2023.
  • Biggest five-year swings in Deferred Taxes: skyrocketed 3150.0% in 2022 and later tumbled 350.0% in 2024.
  • Tracing DGX's Deferred Taxes over 5 years: stood at -$44.0 million in 2022, then surged by 77.27% to -$10.0 million in 2023, then soared by 440.0% to $34.0 million in 2024, then tumbled by 138.24% to -$13.0 million in 2025, then soared by 469.23% to $48.0 million in 2026.
  • Business Quant data shows Deferred Taxes for DGX at $48.0 million in Q1 2026, -$13.0 million in Q4 2025, and $110.0 million in Q3 2025.